Log In
Print this Print this

Pulmozyme, dornase alfa

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionRecombinant deoxyribonuclease (DNase) for inhalation
Molecular Target DNA
Mechanism of ActionDegrades nucleic acid
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationCystic fibrosis (CF)
Indication DetailsImprove pulmonary function in patients with cystic fibrosis; Treat advanced cystic fibrosis (CF); Treat cystic fibrosis (CF); Treat mild to moderate cystic fibrosis (CF)
Regulatory Designation Canada - Orphan Drug (Improve pulmonary function in patients with cystic fibrosis)
PartnerChugai Pharmaceutical Co. Ltd.;

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today